Evidence map›Paper›PMID 27708580›Full record

ArticleFrontiers in pharmacology2016

Innovative Strategies to Develop Chemical Categories Using a Combination of Structural and Toxicological Properties.

Monika Batke, Martin Gütlein, Falko Partosch, Ursula Gundert-Remy, Christoph Helma, Stefan Kramer, Andreas Maunz, Madeleine Seeland, Annette Bitsch

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Wiley interdisciplinary reviews. Computational molecular science
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Monika BatkeDepartment Chemikalienbeureilung, Dantenbanken und Expertensysteme, Fraunhofer Institut für Toxikologie und Experimentelle Medizin Hannover, Germany.
Martin GütleinInstitut für Informatik, Johannes Gutenberg-Universität Mainz Mainz, Germany.
Falko PartoschInstitut für Arbeits-, Sozial- und Umweltmedizin, Universitätsmedizin Göttingen Göttingen, Germany.
Ursula Gundert-RemyInstitut für Klinische Pharmakologie und Toxikologie, Charité Universitätsmedizin Berlin Berlin, Germany.
Christoph HelmaIn Silico Toxicology GmbH Basel, Switzerland.
Stefan KramerInstitut für Informatik, Johannes Gutenberg-Universität Mainz Mainz, Germany.
Andreas MaunzOncotest GmbH Freiburg, Germany.
Madeleine SeelandInstitut für Informatik, Technische Universität München München, Germany.
Annette BitschDepartment Chemikalienbeureilung, Dantenbanken und Expertensysteme, Fraunhofer Institut für Toxikologie und Experimentelle Medizin Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest is increasing in the development of non-animal methods for toxicological evaluations. These methods are however, particularly challenging for complex toxicological endpoints such as repeated dose toxicity. European Legislation, e.g., the European Union's Cosmetic Directive and REACH, demands the use of alternative methods. Frameworks, such as the Read-across Assessment Framework or the Adverse Outcome Pathway Knowledge Base, support the development of these methods. The aim of the project presented in this publication was to develop substance categories for a read-across with complex endpoints of toxicity based on existing databases. The basic conceptual approach was to combine structural similarity with shared mechanisms of action. Substances with similar chemical structure and toxicological profile form candidate categories suitable for read-across. We combined two databases on repeated dose toxicity, RepDose database, and ELINCS database to form a common database for the identification of categories. The resulting database contained physicochemical, structural, and toxicological data, which were refined and curated for cluster analyses. We applied the Predictive Clustering Tree (PCT) approach for clustering chemicals based on structural and on toxicological information to detect groups of chemicals with similar toxic profiles and pathways/mechanisms of toxicity. As many of the experimental toxicity values were not available, this data was imputed by predicting them with a multi-label classification method, prior to clustering. The clustering results were evaluated by assessing chemical and toxicological similarities with the aim of identifying clusters with a concordance between structural information and toxicity profiles/mechanisms. From these chosen clusters, seven were selected for a quantitative read-across, based on a small ratio of NOAEL of the members with the highest and the lowest NOAEL in the cluster (< 5). We discuss the limitations of the approach. Based on this analysis we propose improvements for a follow-up approach, such as incorporation of metabolic information and more detailed mechanistic information. The software enables the user to allocate a substance in a cluster and to use this information for a possible read- across. The clustering tool is provided as a free web service, accessible at http://mlc-reach.informatik.uni-mainz.de.

Indexed as

non-animal methodsPredictive Clustering Tree (PCT) methodQSARread acrosstoxicological and structural similarity

Identifiers

PMID27708580
PMCPMC5030828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.